Literature DB >> 12415256

Cachexia in cancer patients.

Michael J Tisdale1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12415256     DOI: 10.1038/nrc927

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  304 in total

1.  JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.

Authors:  Andrea Bonetto; Tufan Aydogdu; Xiaoling Jin; Zongxiu Zhang; Rui Zhan; Leopold Puzis; Leonidas G Koniaris; Teresa A Zimmers
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

2.  Health-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuan.

Authors:  Lisa K Sprod; Michelle C Janelsins; Oxana G Palesh; Jennifer K Carroll; Charles E Heckler; Luke J Peppone; Supriya G Mohile; Gary R Morrow; Karen M Mustian
Journal:  J Cancer Surviv       Date:  2011-12-10       Impact factor: 4.442

3.  An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Authors:  Andrew Stamm; Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

Review 4.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

5.  A clinically translatable mouse model for chemotherapy-related fatigue.

Authors:  Jonathan A Zombeck; Edward G Fey; Gregory D Lyng; Stephen T Sonis
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

Review 6.  Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.

Authors:  Erin E Talbert; Denis C Guttridge
Journal:  Semin Cell Dev Biol       Date:  2015-09-16       Impact factor: 7.727

7.  Minocycline attenuates cardiac dysfunction in tumor-burdened mice.

Authors:  Raymond D Devine; Clayton M Eichenseer; Loren E Wold
Journal:  J Mol Cell Cardiol       Date:  2016-09-20       Impact factor: 5.000

Review 8.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

9.  Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.

Authors:  J N Gordon; T M Trebble; R D Ellis; H D Duncan; T Johns; P M Goggin
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

10.  The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer.

Authors:  Busra Gul; Selma Metintas; Guntulu Ak; Senay Yilmaz; Muzaffer Metintas
Journal:  Support Care Cancer       Date:  2020-10-30       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.